New Targets in Endocrine-Resistant Hormone Receptor–Positive Breast Cancer

Abstract: Endocrine-based treatments are the backbone of initial therapy for advanced hormone receptor–positive breast cancers. Developing new therapeutic strategies to address resistance to endocrine therapy is […]